Alison Drinkwater

Senior Director

INNOMAR STRATEGIES


All Sessions by Alison Drinkwater

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 6, 2020

3:00 pm

3:00 pm

Industry Expert: REAL-WORLD EVIDENCE

Understand How Real-World Evidence Is Impacting Drug Development And Approval

As seen with the expedited approval of the COVID-19 vaccines, governments, industry players and other stakeholders are increasingly being required to incorporate quality data to support their submissions for reimbursement. Explore new approaches using Real World Evidence (RWE) to improve the value proposition of your medicines. Take away actionable insights to:

  • Enhance the efficacy of your medications on individual patient outcomes
  • Evaluate the impact of RWE on overall patient population health in those taking your medication
  • Partner with stakeholders to access data pertinent to reimbursement

Prove and improve the value, efficacy and impact of your medications with RWE

Agenda: Day 2 Oct 7, 2020